InvestorsHub Logo
Followers 240
Posts 12107
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Thursday, 04/02/2020 3:01:40 PM

Thursday, April 02, 2020 3:01:40 PM

Post# of 44784
While I'd certainly like to hear what's happened to the first 3 to receive PLX-PAD, if we don't, but instead hear that several more are getting the drug, I would take that as being equally positive. It would also be positive to hear that German dosing is starting.

It's really frustrating to think that we may have the answer to a worldwide problem, but advancement in treatment moves so slowly because of the intention of the intend of doing things in a clinical way. If it were up to me, compassionate use should make drugs like ours available to Doctors and patients wanting to give it a try, not 3 people, or even dozens, if hundreds want it, they should get it, and each of them should report results. Not as clear as a clinical trial, but if hundreds of critically ill patients try the drug, many of them already on, or about to be put on ventilators, and if many of this group improve, eventually leave the hospital, I believe we're looking at success.

I know that worldwide they're looking for tens of thousands or more ventilators, yet listening to what the normal prognoses is, most who go on the ventilators won't recover. Certainly some people are saved by them, but the greater majority don't. Our drug could be a game changer, but only if we can get it to these people.

Gary